Latest Mucositis Stories
NEW YORK, March 11, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) today announced that it had entered
Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score
MILAN, February 17, 2014 /PRNewswire/ -- BMG Pharma S.r.l.
PRINCETON, N.J., Jan. 6, 2014 /PRNewswire/ -- Soligenix, Inc.
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.